Abiopharma

🔍 Gebbia John J (Director)

Company: SIEBERT FINANCIAL CORP (SIEB)

Report Date: 2026-08-26

Detailed Transactions and Holdings:

• Sold 22,500 shares of Common Stock, $0.01 par value per share (Direct)
  Date: 2026-08-26 | Code: G | equity_swap_involved: 0 | shares_owned_after: 9,804,994.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock, $0.01 par value per share (Direct)
  Date: 2026-08-26 | Code: H | Footnotes: F1
• Holds 0 shares of Common Stock, $0.01 par value per share (Direct)
  Date: 2026-08-26 | Code: H | nature_of_ownership: Control Group | shares_owned_after: 17,060,603.00 | Footnotes: F3

Footnotes:

• F1: The Reporting Person does not directly own any shares of Issuer common stock.
• F2: The Reporting Person and the Reporting Person's spouse, John J. Gebbia, jointly own the John J & Gloria E Gebbia TTEESS UAD 12/8/94 ("Gebbia Living Trust"). The Gebbia Living Trust gifted 22,500 shares of Issuer common stock to family members and individuals which resulted in a net decrease of 22,500 shares of issuer common stock to the Reporting Person's indirect ownership. The Reporting Person indirectly owns 9,804,994 shares of Issuer common stock owned by the Gebbia Living Trust.
• F3: The Reporting Person is part of a control group consisting of family members of the Reporting Person. Members of the control group gifted 22,500 shares of Issuer common stock to individuals not included within the control group. Additionally, a family member of a member in the control group acquired 15,000 shares of Issuer common stock. These events resulted in a net decrease of 7,500 shares of Issuer common stock to the control group. The Reporting Person disclaims beneficial ownership of such shares of Issuer common stock, except to the extent of the Reporting Person's pecuniary interest therein.